血清CA19-9>100 U/mL应视为胰腺IPMN高危征象而非担忧特征
该回顾性研究纳入645例因胰腺导管内乳头状黏液性肿瘤(IPMN)行胰腺切除的患者,比较血清CA19-9>100 U/mL与其他担忧特征和高危征象对浸润性癌的独立预测价值。作者认为CA19-9>100 U/mL应被视为值得考虑手术切除的高危征象。
要点
- CA19-9>100 U/mL对浸润性癌的OR为7.24,强于黄疸、主胰管>10 mm和壁结节>5 mm。
- CA19-9>100 U/mL对高级别异型增生无预测价值。
- CA19-9>100 U/mL应归类为高危征象,而非担忧特征。
核心结论
- 血清CA19-9>100 U/mL的表现更类似于其他高危征象,且似乎是浸润性癌的最强预测因子。
- 血清CA19-9>100 U/mL是值得关注的表现,应考虑手术切除。
研究设计与样本
- 回顾性分析美国一家高容量三级中心所有因IPMN行胰腺切除的患者,共645例。
- 比较临床病理和影像学变量,采用多变量逻辑回归调整担忧特征和高危征象。
主要发现
- 645例中低级别异型增生占49%,高级别异型增生占23%,浸润性癌占28%。
- 血清CA19-9对高级别异型增生无预测价值。
临床怎么用
- 对于IPMN患者,若血清CA19-9>100 U/mL,应视为高危征象并考虑手术切除。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Elevated serum carbohydrate antigen 19-9 was incorporated as a worrisome feature in the International Association of Pancreatology 2017 Fukuoka guidelines and is associated with an increased risk of invasive carcinoma. We compared the independent predictive value of carbohydrate antigen 19-9 >100 U/mL with other worrisome feature and high-risk stigmata to better delineate its utility and importance. METHODS: We conducted a retrospective analysis of all patients who underwent pancreatic resection for intraductal papillary mucinous neoplasms at a high-volume tertiary center in the United States. Clinicopathologic and radiologic variables were compared by the final pathologic status. Multivariable logistic regression was used to adjust for worrisome feature and high-risk stigmata. RESULTS: Of 645 patients who underwent pancreatectomy, 49% had low-grade dysplasia, 23% had high-grade dysplasia, and 28% had invasive carcinoma. A greater proportion of patients with invasive carcinoma had serum carbohydrate antigen 19-9 levels >100 U/mL (30% vs 5% vs 4%, P < .001). Multivariable analysis revealed that serum carbohydrate antigen 19-9 >100 U/mL (odds ratio, 7.24, P < .001), jaundice (odds ratio, 6.04, P < .001), main pancreatic duct diameter >10 mm (odds ratio, 4.05, P < .001), and mural nodules >5 mm (odds ratio, 3.12, P < .001) were significant predictors of invasive carcinoma. Serum carbohydrate antigen 19-9 was not predictive of high-grade dysplasia. CONCLUSION: Serum carbohydrate antigen 19-9 >100 U/mL performed more similarly to other high-risk stigmata and appeared to be the strongest predictor of invasive carcinoma. Serum carbohydrate antigen 19-9 >100 U/mL is a concerning finding that warrants consideration of surgical resection.
引用
- Servin-Rojas M, Fernández-Del Castillo C, Mohamed M, et al. Serum carbohydrate antigen 19-9 greater than 100 and risk of invasive carcinoma in pancreatic intraductal papillary mucinous neoplasms: Worrisome feature or high-risk stigmata? Surgery. 2025. PMID: 40513170. doi:10.1016/j.surg.2025.109481
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。